期刊： ADVANCES IN THERAPY, 2021; 38 (5)
Introduction The IMpower110 trial evaluated the efficacy and safety of atezolizumab in previously untreated patients with metastatic non-small cell lu......
期刊： ADVANCES IN THERAPY, 2021; 38 (7)
Introduction Low back pain (LBP) still exists at the follow-up visit in some cases after long fusion arthrodesis for adult scoliosis. However, few ava......
期刊： ADVANCES IN THERAPY, 2021; 38 (9)
Introduction To compare the outcomes of viscoelastic substance injection with air filling in the anterior chamber during foldable capsular vitreous bo......
期刊： ADVANCES IN THERAPY, 2021; 38 (8)
Introduction Cemiplimab may significantly increase overall survival in the first-line treatment of advanced non-small cell lung cancer (NSCLC) with a ......
期刊： ADVANCES IN THERAPY, 2021; 38 (3)
Introduction Recently the phase 3 BEACON trial showed that the combination of encorafenib, cetuximab, and binimetinib versus cetuximab and irinotecan/......
期刊： ADVANCES IN THERAPY, 2021; 38 (6)
Introduction Ophthalmologists are inevitably exposed to tears and ocular discharge during ophthalmologic examinations and are at high risk for SARS-Co......
期刊： ADVANCES IN THERAPY, 2021; 38 (6)
Introduction Both thyroid dysfunction and low responsiveness to clopidogrel have been reported to be associated with increased cardiovascular risk. Ou......
期刊： ADVANCES IN THERAPY, 2021; 38 (6)
Brunner's gland hamartoma is a benign tumor of the duodenum, but has malignant potential with a very low risk of progression into adenocarcinoma. It i......
期刊： ADVANCES IN THERAPY, 2021; 38 (7)
Introduction The gold standard surgical therapy for patients with clinical stage I non-small cell lung cancer (NSCLC) is lobectomy with mediastinal ly......
期刊： ADVANCES IN THERAPY, 2021; 38 (9)
Introduction: Ropeginterferon alfa-2b is a novel mono-pegylated human recombinant interferon (IFN) with the addition of N-terminal proline covalently ......
期刊： ADVANCES IN THERAPY, 2021; 38 (3)
Objective To report on the pioneering clinical experiences of six cases of extraperitoneal laparoscopic kidney transplantation in China. Methods For t......
期刊： ADVANCES IN THERAPY, 2021; 38 (5)
Introduction: Cabozantinib and ramucirumab are approved for the treatment of adults with hepatocellular carcinoma (HCC) following prior sorafenib trea......
期刊： ADVANCES IN THERAPY, 2021; 38 (7)
Background Treatment of hepatocellular carcinoma (HCC) recurrences following liver transplant (LT) is challenging. Most clinical trials of systemic th......
期刊： ADVANCES IN THERAPY, 2021; 38 (8)
Introduction To describe anterior segment optical coherence tomography angiography (AS-OCTA) imaging to monitor corneal vascularisation (CoNV) and sca......
期刊： ADVANCES IN THERAPY, 2021; 38 (6)
Introduction To investigate the effect of combined lipid-lowering therapy on low-density lipoprotein cholesterol (LDL-C) variability and cardiovascula......
